Publications by authors named "Philomena Colucci"

Claim this Profile
P
Pemigatinib for Myeloid/Lymphoid Neoplasms with Rearrangement.
Srdan Verstovsek, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Jay L Patel, Alessandro Rambaldi, Philomena Colucci

NEJM Evid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Confirmation of Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement and Characterization of Treatment Patterns and Outcomes in a Real-World Setting: A US Retrospective Chart Review.
Shreekant Parasuraman, Kimberly Saverno, Kristin M Zimmerman Savill, Philomena Colucci

Acta Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group.
William Shomali, Philomena Colucci, Tracy I George, Jean-Jacques Kiladjian, Cheryl Langford

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST Study.
Aaron T Gerds, Roger M Lyons, Philomena Colucci, Patricia Kalafut, Dilan Paranagama

Clin Lymphoma Myeloma Leuk· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study.
Jeffrey I Zwicker, Dilan Paranagama, David S Lessen, Philomena M Colucci, Michael R Grunwald

Haematologica· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 × 10/L): Final Analysis of an Open-Label Phase 2 Study.
Moshe Talpaz, Josef Prchal, Lawrence Afrin, Murat Arcasoy, Solomon Hamburg, Philomena Colucci

Clin Lymphoma Myeloma Leuk· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.
Ivy Altomare, Shreekant Parasuraman, Dilan Paranagama, Jonathan Kish, Kevin Lord, Philomena Colucci

Clin Lymphoma Myeloma Leuk· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Essential Thrombocythemia Enrolled in the MOST Study.
Abdulraheem Yacoub, Roger Lyons, Srdan Verstovsek, Ryan Shao, David Tin Chu, Philomena Colucci

Clin Lymphoma Myeloma Leuk· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States.
Srdan Verstovsek, Jingbo Yu, Jonathan K Kish, Dilan Paranagama, Jill Kaufman, Philomena Colucci

Ann Hematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study.
Michael R Grunwald, David J Kuter, Ivy Altomare, John M Burke, Aaron T Gerds, Philomena Colucci

Clin Lymphoma Myeloma Leuk· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study.
Michael R Grunwald, John M Burke, David J Kuter, Aaron T Gerds, Brady Stein, Philomena Colucci

Clin Lymphoma Myeloma Leuk· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States.
Michael R Grunwald, Brady L Stein, Ralph V Boccia, Stephen T Oh, Dilan Paranagama, Philomena Colucci

Clin Lymphoma Myeloma Leuk· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.
Ruben Mesa, Ralph V Boccia, Michael R Grunwald, Stephen T Oh, Philomena Colucci

Clin Lymphoma Myeloma Leuk· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data.
Dilan Paranagama, Philomena Colucci, Kristin A Evans, Machaon Bonafede, Shreekant Parasuraman

Exp Hematol Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some aspects of the endocrine profile and management of hormone-dependent male breast cancer.
Nikolay V Dimitrov, Philomena Colucci, Sunil Nagpal

Oncologist· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal polyps.
Philomena M Colucci, Steven H Yale, Christopher J Rall

Clin Med Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of healthcare utilization and direct costs in three degenerative dementias.
Daniel L Murman, Qin Chen, Philomena M Colucci, Christopher C Colenda, Douglas J Gelb

Am J Geriatr Psychiatry· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis